ENTITY

Regeneron Pharmaceuticals (REGN UW)

1
Analysis
Health Care • United States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.
more
•03 May 2026 15:45

Primer: Regeneron Pharmaceuticals (REGN US) - May 2026

Regeneron's growth is propelled by the strong performance of its blockbuster drugs, Eylea HD and Dupixent, with the latter continuing to expand...

Logo
233 Views
Share
•23 Sep 2025 10:45

Primer: Regeneron Pharmaceuticals (REGN UW) - Sep 2025

Regeneron's growth is propelled by the strong performance of its blockbuster drugs, Eylea and Dupixent, alongside a promising and extensive...

Logo
144 Views
Share
x